Table 5.
Day | Untreated wounds | Silver sulphadiazine (1% w/w) | Cream only | LWL (7.5% w/w) | JF (7.5% w/w) |
---|---|---|---|---|---|
1 | 519.62 ± 113.01 | 460.67 ± 100.78 | 388.22 ± 119.65 | 623.80 ± 101.56 | 453.41 ± 48.99 |
3 | 400.59 ± 72.97 | 290.87 ± 77.59 | 310.71 ± 111.47 | 406.40 ± 58.77 | 374.91 ± 163.66 |
5 | 375.50 ± 117.88 | 194.86 ± 58.56** | 242.29 ± 74.09 | 300.69 ± 55.28 | 219.87 ± 30.85 |
7 | 236.99 ± 45.97 | 142.43 ± 52.16 | 159.32 ± 51.24 | 194.11 ± 71.80 | 137.92 ± 27.16 |
9 | 167.41 ± 42.92 | 80.47 ± 39.52** | 103.44 ± 48.03 | 134.58 ± 49.26 | 76.89 ± 23.31** |
11 | 112.74 ± 28.62 | 24.31 ± 18.70*** | 57.61 ± 29.41 | 66.48 ± 21.49* | 40.37 ± 18.00** |
13 | 73.00 ± 26.54 | 13.51 ± 8.70*** | 33.58 ± 18.89 | 26.15 ± 12.00** | 13.74 ± 8.15*** |
15 | 46.14 ± 20.08 | 2.40 ± 2.93*** | 19.87 ± 12.15 | 4.95 ± 3.28** | 3.65 ± 2.60*** |
17 | 27.72 ± 13.20 | 0.63 ± 1.40** | 9.07 ± 8.29 | 0.32 ± 0.43** | 0.63 ± 0.35** |
19 | 17.67 ± 9.75 | 0 | 3.65 ± 4.39** | 0 | 0 |
21 | 17.67 ± 9.57 | 0 | 0.51 ± 0.78** | 0 | 0 |
*P < 0.05, **P < 0.01, and ***P < 0.001 were considered statistically significant compared to the untreated wounds.